Coral Olazagasti, MD

Doctor, wife & mama! Proud #boricua 🇵🇷 Assistant Professor @ Sylvester Cancer Center. Views are my own

[gilberto lopes @GlopesMd]

Voting for UICC’s next President-elect is open.

I am honored to stand as a candidate and grateful for the opportunity to have served on the @UICC Board and chaired the ATOM Coalition.

These experiences, together with our work advancing lung cancer policy through IASLC, have reinforced three convictions:

Listen to members. Strengthen institutions. Turn commitments into measurable progress.

Our achievements belong to the many organisations, advocates, clinicians, policymakers, and partners working together across countries.

If elected, I will bring that same commitment to listening, partnership, and delivery to UICC’s next chapter.

I would be grateful for the support of UICC’s voting members.

Together, we can accomplish more.

#UICC #CancerControl #GlobalOncology

@SclcSMASHERS @FDA @LUNGevity @lungoncdoc @StephenVLiu @HHorinouchi @g_mountzios @sands_jacob @LauraAlderMD @oncodaily @OncoAlert @Latinamd @LuisPaz_Ares @RManochakian @LuisRaezMD @triparnasen @LaurenByersMD @LungCancerEu @alissajcooper @BZhangMD @NaglaAKarimMD @Annechiangmd @IASLC @NCCN @ASCO #WCLC26 @larvol @tribeMDUS @sylvestercancer @oncbrothers @chinmay @Jani_Chinmay @colazagasti @openmedicineHQ @myesmo @openmedkate @openmedben @chadinabhan @YoungLungCancer @OncodailyLung @ClinicalLung #LCSM @LungPolicy @dan_morgxen

[Dr. Estela Rodriguez @Latinamd]

Going on now excellent and passionate @SylvesterCancer Heme-Onc Grand Rounds by @COlazagasti on #lungcancerscreening from Evidence to Equity.

Showing impact of Studying the gaps in knowledge and implementation strategies to improve screening in underrepresented groups. #lcsm #lungscreening

[Coral Olazagasti, MD @COlazagasti]

@DrTracyECrane @SylvesterCancer Impossible to do without your mentorship

[CRANE Lab @DrTracyECrane]

Important work being done in our community to increase awareness and engagement in lung cancer screening!! Great work being led by @COlazagasti at @SylvesterCancer !!

[Lauren Kriger Groner @LaurenGroner]

Outstanding #GrandRounds by Dr. Coral Olazagasti, where she shared her diverse and impactful research portfolio! 🙌

Especially pleased to see her highlight her work around #LungCancerScreening w more inclusive guidelines across our diverse South Florida population! 🧡💚👏👏👏

[Coral Olazagasti, MD @COlazagasti]

@LaurenGroner @SylvesterCancer @Latinamd @GlopesMd @Jani_Chinmay @DrTracyECrane @KobetzErin @DrSDNimer @JTrentMDPhD Thank you! I love collaborating with you

[Isabel Preeshagul @ipreeshagul]

My first #lead2026 was one for the books!
- cancer updates
- AI + medicine
- mentorship
-advocacy
- negotiation
- watched @rachnatshroff beautiful acceptance speech -woman oncologist of the yr

We laughed + cried and came out stronger than ever! Cheers to this wolf pack!

[Coral Olazagasti, MD @COlazagasti]

So excited to do this work alongside you @LaurenGroner

[Lauren Kriger Groner @LaurenGroner]

We had a blast filming the #LungCancerScreening promotional videos for our #BreatheEasy initiative, led by Dr. @COlazagasti @SylvesterCancer 🧡💚🫁

Videos will be available in English, Spanish, and Haitian Creole!

And how awesome is our t-shirt?!

#EarlyDetectionSavesLives

[Coral Olazagasti, MD @COlazagasti]

@LaurenGroner @umiamimedicine @SylvesterCancer @KobetzErin @Latinamd @Jani_Chinmay @DrSDNimer Congratulations 🎉

[Narjust Florez, MD, FASCO @NarjustFlorezMD]

Thank you all for joining us for a great discussion and solution seeking conversations about the existing gaps in the care of our patients with lung cancer.

#BTGLung26 @OncLive

[Jeff Yang MD FACS @ChiFuJeffYang]

I was recently interviewed for this New York Times story by Paula Span on the lifesaving impact of lung cancer screening.

Thank you to Paula for shining a light on this important issue, and to Mr. Dennis Schmidt for sharing your powerful story. Early detection saves lives, and I hope this piece inspires continued efforts to expand awareness of and access to lung cancer screening!

https://t.co/0lIKZqB16C

[Misty Dawn Shields @drshieldsmd]

Grateful for the friendships, collaborations, and support of our amazing thoracic oncology community!

Thankful to the amazing co-chairs @NarjustFlorezMD & @DrEdKim for the kind invitation.

An honor to serve as the SCLC session lead where we discussed the unmet needs in our clinical practice, trials, and translational research that remain to be answered to best care for our @SclcSMASHERS & their loved ones.

❓How can we make the highest quality care accessible for all?
🗺️ With all of these new options, what is the best way to sequence our strategies?
🧬 Importantly, how can we better support biomarker research to help expedite & identify WHO should get WHAT treatment?

We have made so much progress in the last 5 years! We must press on, work together, be creative, inquisitive, observant, persistent, and committed to never give up HOPE!

#BTG2026 @onclive #SCLCSMASHERS @lungevity @lungoncdoc @triparnasen @alissajcooper @COlazagasti @peters_solange @PatelOncology @NouraChoudhury @youngkwangchae @ElaineShumMD

[OncLive.com @OncLive]

#BTGLung2026 may have concluded, but our coverage is just getting started 🏁 Thank you to our cochairs @NarjustFlorezMD and @DrEdKim for a wonderful event. We can’t wait to share all the great discussions driving the field of #lcsm forward! @DanaFarber @cityofhope

[Eric K. Singhi, MD @lungoncdoc]

#BTGLung2026 kicks off with small cell lung cancer...

What's known, and what may be changing?

1. Tarlatamab is our preferred 2L option.
2. ADCs are emerging.
3. Will our 1L treatment for ES-SCLC change?

@OncLive @drshieldsmd @NarjustFlorezMD @DrEdKim

[Eric K. Singhi, MD @lungoncdoc]

Top 5 gaps in EGFR+ lung cancer today?

1. Who really needs combo therapy?
2. How do we choose b/w frontline combos?
3. Is TKI monotherapy still enough?
4. Can we reduce toxicity w/o sacrificing efficacy?
5. Should we treat earlier to improve long-term outcomes?

#BTGLung2026

[Lung Cancers Today @Lung_Cancers]

🌐 What do oncologists say about career fulfillment and intent to leave practice?

🌟 @COlazagasti joined us at #ASCO26 to unpack survey findings on the topic and what they showed about the importance of balance, support, and sustainability.

➡️ Watch: https://t.co/nyh6ZtoLD2

[Chinmay Jani @Jani_Chinmay]

Thanks to all collaborators & mentors: @COlazagasti @MDRCollab @Alsbihi93 @MesoDaily @CancerAlliance @SylvesterCancer

[Eric K. Singhi, MD @lungoncdoc]

Paraneoplastic syndromes in SCLC: a rare "board exam" topic, or truly something every practicing oncologist should recognize? Dr. @COlazagasti reviews the latest data at #BTGLung2026.

[Narjust Florez, MD, FASCO @NarjustFlorezMD]

What better way to kick off Bridging the Gaps in Lung Cancer 2026 than with an outstanding session on small cell lung cancer led by Dr. Shields.

An engaging start to a meeting focused on advancing science, strengthening collaboration, and improving care for every patient.

#BridgingTheGaps2026 #SCLC

[Dr. Estela Rodriguez @Latinamd]

#BestofASCO PR🇵🇷 Top Head and Neck #ASCO26 Abstracts presented by @COlazagasti @SylvesterCancer

🔹 Amivantamab (OrigAMI-4): 47% ORR with durable responses in heavily pretreated recurrent/metastatic HNSCC.

🔹 KEYNOTE-689: Perioperative pembrolizumab continues to support a new standard of care for resectable locally advanced HNSCC.

🔹 Ivonescimab in LA-HNSCC Phase 2 (n=36) Neoadjuvant Dual PD-1/VEGF blockade shows ⬆️ pCR 50% and organ preservation. Phase 3 ongoing.

@TotalHealthConf @ASCO #HeadAndNeckCancer #hncsm